Elaine Shanks

In vitro characterisation of the novel positive allosteric modulators of the mGlu5 receptor, LSN2463359 and LSN2814617, and their effects on sleep architecture and operant responding in the rat

Gary Gilmour, Lisa M. Broad, Keith A. Wafford et al. · Neuropharmacology · 2012 · 61 citations

Molecular Pharmacology, Sleep, Vitro Characterisation +15

Preclinical profile of a dopamine D1 potentiator suggests therapeutic utility in neurological and psychiatric disorders

Robert F. Bruns, Stephen N. Mitchell, Keith A. Wafford et al. · Neuropharmacology · 2017 · 48 citations · Full text

Neuropsychology, Psychotropic Medication, Neurotransmitter +21

REM sleep homeostasis in the absence of REM sleep: Effects of antidepressants

Andrew McCarthy, Keith A. Wafford, Elaine Shanks et al. · Neuropharmacology · 2016 · 40 citations · Full text

Investigating the role of mGluR2 versus mGluR3 in antipsychotic-like effects, sleep-wake architecture and network oscillatory activity using novel Han Wistar rats lacking mGluR2 expression

Christian M. Wood, Keith A. Wafford, Andrew McCarthy et al. · Neuropharmacology · 2018 · 19 citations · Full text

The Dopamine D1 Receptor Positive Allosteric Modulator Mevidalen (LY3154207) Enhances Wakefulness in the Humanized D1 Mouse and in Sleep-Deprived Healthy Male Volunteers

Andrew P. McCarthy, Kjell Svensson, Elaine Shanks et al. · Journal of Pharmacology and Experimental Therapeutics · 2021 · 10 citations · Full text